Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.
BACKGROUND
Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have been made. However, passive immunization based on mAbs may require a cocktail of mAbs with broader specificity in order to provide full protection since mAbs are generally specific for single epitopes. Chicken immunoglobulins (IgY) found in egg yolk have been used mainly for treatment of infectious diseases of the gastrointestinal tract. Because the recent epidemic of highly pathogenic avian influenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have introduced mass vaccination of poultry with H5N1 virus vaccines. We reasoned that IgY from consumable eggs available in supermarkets in Vietnam could provide protection against infections with HPAIV H5N1.


RESULTS
We found that H5N1-specific IgY that are prepared from eggs available in supermarkets in Vietnam by a rapid and simple water dilution method cross-protect against infections with HPAIV H5N1 and related H5N2 strains in mice. When administered intranasally before or after lethal infection, the IgY prevent the infection or significantly reduce viral replication resulting in complete recovery from the disease, respectively. We further generated H1N1 virus-specific IgY by immunization of hens with inactivated H1N1 A/PR/8/34 as a model virus for the current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal influenza virus infection.


CONCLUSIONS
The findings suggest that readily available H5N1-specific IgY offer an enormous source of valuable biological material to combat a potential H5N1 pandemic. In addition, our study provides a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza outbreaks, including the current H1N1 pandemic.
Nguyen
Huan H
HH
International Vaccine Institute, Seoul, Korea. hhnguyen@ivi.int
Tumpey
Terrence M
TM
Park
Hae-Jung
HJ
Byun
Young-Ho
YH
Tran
Linh D
LD
Nguyen
Van D
VD
Kilgore
Paul E
PE
Czerkinsky
Cecil
C
Katz
Jacqueline M
JM
Seong
Baik Lin
BL
Song
Jae Min
JM
Kim
Young Bong
YB
Do
Hoa T
HT
Nguyen
Tung
T
Nguyen
Cam V
CV
D000818:Animals; D000914:Antibodies, Viral; D001717:Birds; D002645:Chickens; D004531:Eggs / Q000821:virology; D007114:Immunization; D007136:Immunoglobulins / Q000096:biosynthesis* / Q000627:therapeutic use; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines; D051379:Mice; D058873:Pandemics / Q000517:prevention & control; D011200:Poultry; D014744:Vietnam
D000914:Antibodies, Viral; C016512:IgY; D007136:Immunoglobulins; D007252:Influenza Vaccines
PLoS Med. 2007 May;4(5):e178
17535101
Virol J. 2008 Oct 28;5:130
18957074
Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:185-92
15298626
Hong Kong Med J. 2006 Dec;12(6):489
17148811
J Virol. 2009 Jun;83(11):5825-34
19297490
Ups J Med Sci. 2003;108(2):129-40
14649324
Emerg Infect Dis. 2005 Oct;11(10):1515-21
16318689
Pediatr Pulmonol. 2008 Sep;43(9):892-9
18680179
Ups J Med Sci. 1999;104(3):179-89
10680951
Lancet. 2000 Mar 4;355(9206):827-35
10711940
Caries Res. 1997;31(4):268-74
9197932
Immunol Today. 1995 Aug;16(8):392-8
7546196
J Clin Immunol. 1986 Jan;6(1):74-86
3514654
Nature. 2005 Oct 20;437(7062):1108
16228009
Clin Chem. 1991 Mar;37(3):411-4
2004449
PLoS One. 2009;4(5):e5476
19421326
Science. 2005 Oct 7;310(5745):77-80
16210530
Immunol Res. 2000;21(1):1-6
10803878
J Infect Dis. 2006 Jun 15;193(12):1626-9
16703504
Infect Dis Clin North Am. 1987 Jun;1(2):459-78
3332798
J Agric Food Chem. 2005 Nov 2;53(22):8421-31
16248532
Epidemiol Infect. 2009 Jan;137(1):1-21
18700992
N Engl J Med. 2005 Dec 22;353(25):2667-72
16371632
Respir Res. 2006 Oct 14;7:126
17040574
J Immunol Methods. 1993 Apr 2;160(2):207-14
8459107
Curr Protoc Neurosci. 2009 Jul;Chapter 5:Unit 5.5
19575471
Lancet. 2005 Oct 1;366(9492):1175-81
16198766
J Dairy Sci. 2004 Dec;87(12):4073-9
15545368
Clin Microbiol Rev. 2000 Oct;13(4):602-14
11023960
Dev Biol (Basel). 2007;130:3-167
18655239
Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92
18625765
J Infect Dis. 1998 Dec;178(6):1592-6
9815209
J Infect Dis. 2001 Feb 1;183(3):368-76
11133367
Immunology. 2000 Dec;101(4):467-73
11122450
Poult Sci. 1993 Oct;72(10):1807-12
8415358
J Virol. 2005 Sep;79(18):11788-800
16140756
Pediatr Pulmonol. 2003 Jun;35(6):433-40
12746939
J Infect Dis. 2007 Jul 15;196(2):249-57
17570112
J Clin Microbiol. 1999 Apr;37(4):937-43
10074505
J Agric Food Chem. 2008 Dec 24;56(24):11638-42
19053374
N Engl J Med. 2008 Jun 12;358(24):2573-84
18550874